Prentice Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,251
Closed -$112K 137
2022
Q2
$112K Sell
1,251
-956
-43% -$96.9K 0.11% 55
2022
Q1
$247K Buy
+2,207
New +$233K 0.12% 87
2021
Q4
Sell
-2,577
Closed -$323K 218
2021
Q3
$323K Buy
2,577
+26
+1% +$3.37K 0.16% 66
2021
Q2
$317K Buy
2,551
+501
+24% +$62.9K 0.16% 64
2021
Q1
$242K Buy
+2,050
New +$240K 0.13% 76

Other funds holding MDT

Prentice Wealth Management's MDT Position: Q3 2022 in Review

Prentice Wealth Management sold out of Medtronic (MDT) in Q3 2022, closing a stake of 1,251 shares — an estimated $112K sold.

Prentice Wealth Management first reported a position in MDT in Q1 2021 and held it in 5 quarters. The position peaked at $323K in Q3 2021. 1,932 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Prentice Wealth Management reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Prentice Wealth Management sold 1,251 Medtronic shares in Q3 2022, an estimated $112K.
  • Prentice Wealth Management first reported a position in Medtronic in Q1 2021 and held it in 5 quarters.
  • Prentice Wealth Management's Medtronic position peaked at $323K in Q3 2021.
  • 1,932 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Prentice Wealth Management's 13F filing for Q3 2022, filed 19 Oct 2022.